As the EMA recommends Bimervax's as a booster, global plans for Covid-19 vaccin...
The agreements could broaden the access to the GSK/ViiV’s long-acting PrEP in lo...
Ibrexafungerp is now being evaluated in Phase III clinical trials to treat invas...
The facility is expected to enable manufacturing of drug products for Kenya and ...
The agency is partnering with the Lupus Research Alliance to tackle therapeutic ...
Better patient engagement is shown to improve the quality and equitability of cl...
The approval’s announcement comes amidst a drive for an overhaul of the accelera...
In alignment with its Overdose Prevention Framework, the US FDA approved the nal...
For medical products specifically (drugs, diagnostics, and devices), the FDA is ...
“It looks like the Solicitor General is siding with Teva by requesting the Supre...
Prescription drug middlemen are shifting away from rebates to increasingly large...
A new CDC study highlights just how violent the recent past has been in the U.S....
What happened to the market for monkeys? Are some drugs too cheap? And why are b...
The FDA has released a new plan allowing developers of medical devices that rely...
A federal judge Thursday reversed a major Obamacare provision requiring plans to...
The FDA approved selling Narcan without a prescription, setting the overdose-rev...